Additionally, SPARC overexpression in implanted gastric cancer cells interfered with the epithelial-mesenchymal transition and decreased cell viability and migratory ability; further, SPARC overexpression also inhibited VEGF expression [184,185]. This evidence concerns the gene SPARC and gastric cancer.